• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Research in Oncology
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 21 (2025)
Volume Volume 20 (2024)
Volume Volume 19 (2023)
Volume Volume 18 (2022)
Issue Issue 2
Issue Issue 1
Volume Volume 17 (2021)
Volume Volume 16 (2020)
Volume Volume 15 (2019)
Volume Volume 14 (2018)
Volume Volume 13 (2017)
Volume Volume 12 (2016)
Alghandour, R., El-Ashwah, S., Emarah, Z., Elashwah, S., Saleh, L., Elmaria, M., Ebrahim, M., ElKhodary, T., Saleh, G., EL-Sheltawy, N., Zaki, H., Shamaa, S. (2022). A Diagnostic Dilemma of Encephalopathy in Acute Myeloid Leukemia Patient with Twice COVID-19 Infection: A Case Report. Research in Oncology, 18(2), 76-80. doi: 10.21608/resoncol.2022.167065.1176
Reham Alghandour; Shaimaa El-Ashwah; Ziad Emarah; Salma Elashwah; Layla M. Saleh; Marwa O. Elmaria; Mohamed A. Ebrahim; Tawfik ElKhodary; Gehad A. Saleh; Nada F. EL-Sheltawy; Heba Zaki; Sameh Shamaa. "A Diagnostic Dilemma of Encephalopathy in Acute Myeloid Leukemia Patient with Twice COVID-19 Infection: A Case Report". Research in Oncology, 18, 2, 2022, 76-80. doi: 10.21608/resoncol.2022.167065.1176
Alghandour, R., El-Ashwah, S., Emarah, Z., Elashwah, S., Saleh, L., Elmaria, M., Ebrahim, M., ElKhodary, T., Saleh, G., EL-Sheltawy, N., Zaki, H., Shamaa, S. (2022). 'A Diagnostic Dilemma of Encephalopathy in Acute Myeloid Leukemia Patient with Twice COVID-19 Infection: A Case Report', Research in Oncology, 18(2), pp. 76-80. doi: 10.21608/resoncol.2022.167065.1176
Alghandour, R., El-Ashwah, S., Emarah, Z., Elashwah, S., Saleh, L., Elmaria, M., Ebrahim, M., ElKhodary, T., Saleh, G., EL-Sheltawy, N., Zaki, H., Shamaa, S. A Diagnostic Dilemma of Encephalopathy in Acute Myeloid Leukemia Patient with Twice COVID-19 Infection: A Case Report. Research in Oncology, 2022; 18(2): 76-80. doi: 10.21608/resoncol.2022.167065.1176

A Diagnostic Dilemma of Encephalopathy in Acute Myeloid Leukemia Patient with Twice COVID-19 Infection: A Case Report

Article 5, Volume 18, Issue 2, December 2022, Page 76-80  XML PDF (409.06 K)
Document Type: Case reports
DOI: 10.21608/resoncol.2022.167065.1176
View on SCiNiTO View on SCiNiTO
Authors
Reham Alghandour email orcid 1; Shaimaa El-Ashwah2; Ziad Emarahorcid 1; Salma Elashwah1; Layla M. Saleh3; Marwa O. Elmaria4; Mohamed A. Ebrahim1; Tawfik ElKhodary1; Gehad A. Saleh5; Nada F. EL-Sheltawy1; Heba Zaki1; Sameh Shamaa1
1Department of Medical Oncology, Faculty of Medicine, Mansoura University, Mansoura, Egypt
2Department of Clinical Hematology, Faculty of Medicine, Mansoura University, Mansoura, Egypt
3Department of Clinical Pathology, Faculty of Medicine, Mansoura University, Mansoura, Egypt
4Department of Chest Medicine, Faculty of Medicine, Mansoura University, Mansoura, Egypt
5Department of Diagnostic and Interventional Radiology, Faculty of Medicine, Mansoura University, Mansoura, Egypt
Abstract
Background: During the COVID‐19 pandemic, there was limited data about the appropriate management of acute myeloid leukemia (AML) with COVID-19 infection and the possible post-COVID-19 complications reported in acute leukemia patients.
Case presentation: We report a 52-year-old lady with AML and confirmed twice SARS-CoV-2 infection. The first infection was just after the diagnosis of AML before the administration of induction therapy, and the second infection was just after she received the salvage therapy. The COVID-19 infection was confirmed by qRT-PCR and high-resolution non-contrast computerized tomography of the chest. Unfortunately, the patient developed post-covid neurological complications, disturbed consciousness level, and encephalopathy. The COVID-19 infection may have triggered encephalopathy or exaggerated the neurological toxicity of cytarabine even in a small dose. Another possible explanation is the exaggeration of cytokine storm by the administration of granulocyte-stimulating factors used in salvage therapy.
Conclusion: Management of COVID-19 infection in AML patients faces many challenges. These patients are more vulnerable and susceptible to many complications and high mortality rates. The treatment approach needs to be tailored to overcome the interaction between the treatment adverse events and the biology of covid-19 infection.
Keywords
Acute myeloid leukemia; COVID-19; Encephalopathy
Statistics
Article View: 479
PDF Download: 433
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.